197 related articles for article (PubMed ID: 37899809)
1. Hypokinetic Dysarthria in Parkinson's Disease: A Narrative Review.
Atalar MS; Oguz O; Genc G
Sisli Etfal Hastan Tip Bul; 2023; 57(2):163-170. PubMed ID: 37899809
[TBL] [Abstract][Full Text] [Related]
2. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
[TBL] [Abstract][Full Text] [Related]
3. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
[TBL] [Abstract][Full Text] [Related]
4. Speech and language therapy treatment on hypokinetic dysarthria in Parkinson disease: Systematic review and meta-analysis.
Muñoz-Vigueras N; Prados-Román E; Valenza MC; Granados-Santiago M; Cabrera-Martos I; Rodríguez-Torres J; Torres-Sánchez I
Clin Rehabil; 2021 May; 35(5):639-655. PubMed ID: 33233932
[TBL] [Abstract][Full Text] [Related]
5. Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Hattori M; Kawabata K; Hara K; Ito M; Fujimoto Y; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G
J Neural Transm (Vienna); 2017 Dec; 124(12):1547-1556. PubMed ID: 29098450
[TBL] [Abstract][Full Text] [Related]
6. An Efficacy Study of Voice Quality Using Cepstral Analyses of Phonation in Parkinson's Disease before and after SPEAK-OUT!®.
Boutsen FR; Park E; Dvorak JD
Folia Phoniatr Logop; 2023; 75(1):35-42. PubMed ID: 35817007
[TBL] [Abstract][Full Text] [Related]
7. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
[TBL] [Abstract][Full Text] [Related]
8. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.
Sauvageau VM; Roy JP; Langlois M; Macoir J
Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915
[TBL] [Abstract][Full Text] [Related]
9. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
K-Y Ma J; Schneider CB; Hoffmann R; Storch A
J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
[TBL] [Abstract][Full Text] [Related]
10. Lee Silverman Voice Treatment to Improve Speech in Parkinson's Disease: A Systemic Review and Meta-Analysis.
Pu T; Huang M; Kong X; Wang M; Chen X; Feng X; Wei C; Weng X; Xu F
Parkinsons Dis; 2021; 2021():3366870. PubMed ID: 35070257
[TBL] [Abstract][Full Text] [Related]
11. Dysarthria and Speech Intelligibility Following Parkinson's Disease Globus Pallidus Internus Deep Brain Stimulation.
Chiu SY; Tsuboi T; Hegland KW; Herndon NE; Shukla AW; Patterson A; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
J Parkinsons Dis; 2020; 10(4):1493-1502. PubMed ID: 32955467
[TBL] [Abstract][Full Text] [Related]
12. The impact of Lee Silverman Voice Treatment (LSVT LOUD®) on voice, communication, and participation: Findings from a prospective, longitudinal study.
Bryans LA; Palmer AD; Anderson S; Schindler J; Graville DJ
J Commun Disord; 2021; 89():106031. PubMed ID: 33259945
[TBL] [Abstract][Full Text] [Related]
13. [Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria].
Pinto S; Ghio A; Teston B; Viallet F
Rev Neurol (Paris); 2010 Oct; 166(10):800-10. PubMed ID: 20800250
[TBL] [Abstract][Full Text] [Related]
14. Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease.
Tripoliti E; Strong L; Hickey F; Foltynie T; Zrinzo L; Candelario J; Hariz M; Limousin P
Mov Disord; 2011 Nov; 26(13):2434-6. PubMed ID: 21953693
[TBL] [Abstract][Full Text] [Related]
15. Acoustic evaluation of short-term effects of repetitive transcranial magnetic stimulation on motor aspects of speech in Parkinson's disease.
Eliasova I; Mekyska J; Kostalova M; Marecek R; Smekal Z; Rektorova I
J Neural Transm (Vienna); 2013 Apr; 120(4):597-605. PubMed ID: 23254927
[TBL] [Abstract][Full Text] [Related]
16. Dysprosody and stimulus effects in Cantonese speakers with Parkinson's disease.
Ma JK; Whitehill T; Cheung KS
Int J Lang Commun Disord; 2010; 45(6):645-55. PubMed ID: 19995207
[TBL] [Abstract][Full Text] [Related]
17. Acoustic and Perceptual Consequences of Speech Cues for Mandarin Speakers With Parkinson's Disease.
Hsu SC; McAuliffe MJ; Lin P; Wu RM; Levy ES
Am J Speech Lang Pathol; 2019 May; 28(2):521-535. PubMed ID: 31136238
[TBL] [Abstract][Full Text] [Related]
18. The BioVisualSpeech Serious Game with Voice Exercises for People with Parkinson's Disease with Hypokinetic Dysarthria.
Viana T; Cavaco S
Stud Health Technol Inform; 2022 Jun; 290():919-923. PubMed ID: 35673153
[TBL] [Abstract][Full Text] [Related]
19. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings.
Tjaden K; Wilding GE
J Speech Lang Hear Res; 2004 Aug; 47(4):766-83. PubMed ID: 15324285
[TBL] [Abstract][Full Text] [Related]
20. Effects of an intensive voice treatment on articulatory function and speech intelligibility in children with motor speech disorders: A phase one study.
Langlois C; Tucker BV; Sawatzky AN; Reed A; Boliek CA
J Commun Disord; 2020; 86():106003. PubMed ID: 32505858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
